SETD2 and hepatocellular carcinoma: The results from SETD2 silencing and SETD2 overexpression experiments demonstrated that SETD2 could promote the proliferation and migration of HCC cell lines; that is, SETD2 has an important role in promoting hepatocellular carcinoma.